<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(6)</volume><submitter>Wang CZ</submitter><funding>Qingdao University</funding><pubmed_abstract>Doxorubicin (DOX) possesses strong anti-tumor effects but is limited by its irreversible cardiac toxicity. The relationship between exercise, a known enhancer of cardiovascular health, and DOX-induced cardiotoxicity has been a focus of recent research. Exercise has been suggested to mitigate DOX's cardiac harm by modulating the Yes-associated protein (YAP) and Signal transducer and activator of transcription 3 (STAT3) pathways, which are crucial in regulating cardiac cell functions and responses to damage. This study aimed to assess the protective role of exercise preconditioning against DOX-induced cardiac injury. We used Sprague-Dawley rats, divided into five groups (control, DOX, exercise preconditioning (EP), EP-DOX, and verteporfin + EP + DOX), to investigate the potential mechanisms. Our findings, including echocardiography, histological staining, Western blot, and q-PCR analysis, demonstrated that exercise preconditioning could alleviate DOX-induced cardiac dysfunction and structural damage. Notably, exercise preconditioning enhanced the nuclear localization and co-localization of YAP and STAT3. Our study suggests that exercise preconditioning may counteract DOX-induced cardiotoxicity by activating the YAP/STAT3 pathway, highlighting a potential therapeutic approach for reducing DOX's cardiac side effects.</pubmed_abstract><journal>Heliyon</journal><pagination>e27035</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10955211</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Exercise preconditioning inhibits doxorubicin-induced cardiotoxicity via YAP/STAT3 signaling.</pubmed_title><pmcid>PMC10955211</pmcid><pubmed_authors>Wang CZ</pubmed_authors><pubmed_authors>Liang ZD</pubmed_authors><pubmed_authors>Wang JT</pubmed_authors><pubmed_authors>Guo HZ</pubmed_authors><pubmed_authors>Wang SQ</pubmed_authors><pubmed_authors>Luo LJ</pubmed_authors><pubmed_authors>Leng JZ</pubmed_authors><pubmed_authors>Yuan Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Exercise preconditioning inhibits doxorubicin-induced cardiotoxicity via YAP/STAT3 signaling.</name><description>Doxorubicin (DOX) possesses strong anti-tumor effects but is limited by its irreversible cardiac toxicity. The relationship between exercise, a known enhancer of cardiovascular health, and DOX-induced cardiotoxicity has been a focus of recent research. Exercise has been suggested to mitigate DOX's cardiac harm by modulating the Yes-associated protein (YAP) and Signal transducer and activator of transcription 3 (STAT3) pathways, which are crucial in regulating cardiac cell functions and responses to damage. This study aimed to assess the protective role of exercise preconditioning against DOX-induced cardiac injury. We used Sprague-Dawley rats, divided into five groups (control, DOX, exercise preconditioning (EP), EP-DOX, and verteporfin + EP + DOX), to investigate the potential mechanisms. Our findings, including echocardiography, histological staining, Western blot, and q-PCR analysis, demonstrated that exercise preconditioning could alleviate DOX-induced cardiac dysfunction and structural damage. Notably, exercise preconditioning enhanced the nuclear localization and co-localization of YAP and STAT3. Our study suggests that exercise preconditioning may counteract DOX-induced cardiotoxicity by activating the YAP/STAT3 pathway, highlighting a potential therapeutic approach for reducing DOX's cardiac side effects.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2025-04-04T20:07:54.069Z</modification><creation>2025-04-04T20:07:54.069Z</creation></dates><accession>S-EPMC10955211</accession><cross_references><pubmed>38515673</pubmed><doi>10.1016/j.heliyon.2024.e27035</doi></cross_references></HashMap>